+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antibacterial Vaccines Market - Global Forecast 2025-2030- Product Image
Antibacterial Vaccines Market - Global Forecast 2025-2030- Product Image
Sale

Antibacterial Vaccines Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6142362
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Antibacterial vaccines are playing a pivotal role in reshaping global public health strategies, supported by technological advances, regulatory evolution, and collaborative frameworks. Senior decision-makers now face a transforming market where targeted immunization solutions are fast becoming the mainstay for proactive disease management.

Market Snapshot: Antibacterial Vaccine Sector Outlook

The global antibacterial vaccine market is driven by innovations in immunogen design, data-enabled research, and heightened awareness of antimicrobial resistance. The landscape has shifted to prioritize immunization over traditional antibiotic therapies, with investment in vaccine research, rapid development cycles, and integrated supply chain logistics supporting sustainable growth. As stakeholders from public and private sectors combine efforts, antibacterial vaccines are helping organizations reduce hospitalizations, contain resistant bacterial strains, and ensure more efficient healthcare delivery models.

Scope & Segmentation of Antibacterial Vaccine Market

This report analyzes the market using robust segmentation and regional insights, while highlighting technological innovations and key investment areas.

  • Vaccine Types: Inactivated, Live Attenuated, Subunit (including Conjugate, Polysaccharide, Protein Subunit)
  • Indications: Meningococcal Disease, Pertussis, Pneumococcal Disease, Typhoid Fever
  • End User Segments: Clinics, Hospitals
  • Distribution Channels: Government Supply, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
  • Administration Routes: Intradermal, Intramuscular, Oral, Subcutaneous
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Merck & Co., Inc., CSL Limited, Valneva SE, Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Emergent BioSolutions, Inc., Takeda Pharmaceutical Company Limited
  • Technological Advances: mRNA platforms, high-throughput screening, advanced adjuvant design, digital supply chain solutions

Key Takeaways for Strategic Decision-Making

  • Scientific breakthroughs in immunogen design, structure-guided epitope mapping, and adjuvant optimization are shortening development cycles and expanding vaccine portfolios.
  • Collaborative consortia between academic, government, and industry players are promoting scale-up, discovery, and global distribution, especially in low- and middle-income markets.
  • mRNA and nanoparticle technologies, adapted from viral platforms, are now being applied to bacterial targets, enabling rapid update capabilities for emerging pathogenic threats.
  • Digital innovation in supply chain visibility and traceability, combined with real-time analytics and electronic immunization registries, is streamlining procurement and resource allocation.
  • Public-private manufacturing partnerships and decentralized regional fill-finish facilities are minimizing dependency risks and extending immunization reach.
  • Strategic alliances and acquisitions are enriching industry pipelines and enabling rapid response to shifts in regional disease burden.

Tariff Impact on Antibacterial Vaccine Supply Chains

The introduction of United States tariffs in 2025 on specialized manufacturing inputs is increasing operational costs and prompting manufacturers to adopt dual-sourcing and hybrid production strategies. While some regulatory exemptions are in place for certain public health programs, these measures can be time-consuming and delay access. In response, organizations are enhancing scenario planning, securing multi-year procurement agreements, and investing in geographically diverse manufacturing to maintain resilience and mitigate tariff risk.

Methodology & Data Sources

This comprehensive analysis draws on structured interviews, quantitative surveys, and in-depth secondary research. Key informants included immunologists, supply chain experts, and health policy leaders. Triangulation across data sources ensured robust validation, with all inputs systematically screened for relevance and accuracy.

Why This Report Matters for Decision-Makers

  • Enables identification of high-growth opportunity segments and the technologies driving competitive advantage in the antibacterial vaccine market.
  • Supports informed investment strategies by detailing collaborative models, supply chain adjustments, and successful deployment frameworks from leading regions.
  • Equips senior leaders to anticipate regulatory, procurement, and partnership trends, supporting agile responses to market disruptions and public health needs.

Conclusion

Advanced immunization technologies and collaborative strategies are guiding the antibacterial vaccine market into an era defined by prevention and resilience. This report offers actionable insights for stakeholders striving to optimize impact, address regulatory demands, and drive sustainable growth in evolving healthcare landscapes.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in mRNA-based antibacterial vaccine candidates targeting drug-resistant pathogens
5.2. Integration of adjuvant technologies to boost immunogenicity in elderly populations
5.3. Strategic partnerships between biotech firms and global health agencies for vaccine distribution in low-income countries
5.4. Regulatory approvals and fast-track designations accelerating commercialization of novel antibacterial vaccines
5.5. Development of multivalent conjugate vaccines addressing multiple bacterial serotypes in pediatric immunization schedules
5.6. Implementation of AI-driven antigen discovery platforms to identify novel bacterial targets for vaccine development
5.7. Increasing investments in phage-derived vaccine platforms for prevention of multidrug-resistant Gram-negative infections
5.8. Market entry of combination vaccines targeting both bacterial and viral respiratory infections to streamline immunization programs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antibacterial Vaccines Market, by Type
8.1. Introduction
8.2. Inactivated
8.3. Live Attenuated
8.4. Subunit
8.4.1. Conjugate
8.4.2. Polysaccharide
8.4.3. Protein Subunit
9. Antibacterial Vaccines Market, by Indication
9.1. Introduction
9.2. Meningococcal Disease
9.3. Pertussis
9.4. Pneumococcal Disease
9.5. Typhoid Fever
10. Antibacterial Vaccines Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Hospitals
11. Antibacterial Vaccines Market, by Distribution Channel
11.1. Introduction
11.2. Government Supply
11.3. Hospital Pharmacies
11.4. Online Pharmacies
11.5. Retail Pharmacies
12. Antibacterial Vaccines Market, by Administration Route
12.1. Introduction
12.2. Intradermal
12.3. Intramuscular
12.4. Oral
12.5. Subcutaneous
13. Americas Antibacterial Vaccines Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Antibacterial Vaccines Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Antibacterial Vaccines Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. GlaxoSmithKline plc
16.3.3. Sanofi S.A.
16.3.4. Merck & Co., Inc.
16.3.5. CSL Limited
16.3.6. Valneva SE
16.3.7. Bharat Biotech International Limited
16.3.8. Serum Institute of India Pvt. Ltd.
16.3.9. Emergent BioSolutions, Inc.
16.3.10. Takeda Pharmaceutical Company Limited
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. ANTIBACTERIAL VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTIBACTERIAL VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTIBACTERIAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTIBACTERIAL VACCINES MARKET: RESEARCHAI
FIGURE 26. ANTIBACTERIAL VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTIBACTERIAL VACCINES MARKET: RESEARCHCONTACTS
FIGURE 28. ANTIBACTERIAL VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIBACTERIAL VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY CONJUGATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY CONJUGATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY POLYSACCHARIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY POLYSACCHARIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY PROTEIN SUBUNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY MENINGOCOCCAL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY MENINGOCOCCAL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY PERTUSSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY PERTUSSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPHOID FEVER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPHOID FEVER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY GOVERNMENT SUPPLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY GOVERNMENT SUPPLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INTRADERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ANTIBACTERIAL VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 92. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 93. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 100. CANADA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 104. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 105. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 163. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 164. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 165. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 166. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 167. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 174. GERMANY ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 175. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 176. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 177. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 178. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 179. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 186. FRANCE ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 199. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 200. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 201. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 202. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 203. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 210. ITALY ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 211. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 212. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 213. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 214. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 215. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 222. SPAIN ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 259. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 260. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 261. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 262. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 263. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 270. DENMARK ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 283. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 284. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 285. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 286. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 287. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 294. QATAR ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 295. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 296. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 297. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 298. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 299. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 306. FINLAND ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 330. NIGERIA ANTIBACTERIAL VACCINES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 331. EGYPT ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 332. EGYPT ANTIBACTERIAL VACCINES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 333. EGYPT ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2018-2024 (USD MILLION)
TABLE 334. EGYPT ANTIBACTERIAL VACCINES MARKET SIZE, BY SUBUNIT, 2025-2030 (USD MILLION)
TABLE 335. EGYPT ANTIBACTERIAL VACCINES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antibacterial Vaccines Market report include:
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Merck & Co., Inc.
  • CSL Limited
  • Valneva SE
  • Bharat Biotech International Limited
  • Serum Institute of India Pvt. Ltd.
  • Emergent BioSolutions, Inc.
  • Takeda Pharmaceutical Company Limited

Related Topics

Related Reports

Porcine Vaccine Global Market Report 2025 - Product Image

Porcine Vaccine Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Porcine Vaccines Market - Global Forecast 2025-2030 - Product Image

Porcine Vaccines Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Tobacco Plant Vaccines Market - Global Forecast 2025-2030 - Product Image

Tobacco Plant Vaccines Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Vaccines Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Type, Indication, Route of Administration, Age Group, and Geography - Product Image

Vaccines Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Type, Indication, Route of Administration, Age Group, and Geography

  • Report
  • 226 Pages
  • Global
From
Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form Type, Route of Administration, Approach, Indication, Packaging - Global Forecast to 2031 - Product Image

Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form Type, Route of Administration, Approach, Indication, Packaging - Global Forecast to 2031

  • Report
  • 239 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.